Based on our preliminary findings, catalase measured in red and white blood cells, along with Paraoxonase 1 measured in plasma, emerged as the most promising candidates among enzymatic antioxidants to distinguish patients with active IBD from healthy controls. The gene discussed is PON1; the disease is inflammatory bowel disease.